Breakthrough in Cancer Research: New Compounds Target RAS Gene to Halt Tumor Growth In a significant advancement in cancer treatment, scientists from the Francis Crick Institute and Vividion Therapeutics have identified chemical compounds that can selectively prevent the cancer-causing RAS gene from interacting with a critical growth pathway. This monumental discovery, published on October 9 in the journal Science, opens the door to a new approach to treating various cancers while minimizing damage to healthy cells.

Obviously, a guest OpEd by Gene Bouie struck a nerve and moved by narcissism, Gusciora delivered an OpEd that read like a campaign speech.

General Knowledge Quiz in I of You Know What. Challenge yourself on topics like Classic Song Titles, Egyptian Mythology, Geography, and much more!

ALT: a frog sits on a leaf in the rain

Dayton, Ohio

CD99L2 gene-inactivation inhibits leukocyte entry into the CNS during active MOG35-55-induced EAE. No detrimental effect on the immune response was observed.